Desoximetasone 0.25% spray, adrenal suppression and efficacy, in extensive plaque psoriasis.
CONCLUSIONS: Considerable improvement can be achieved with short term potent topical corticosteroid treatment even in patients with severe, extensive psoriasis. For such use, topical desoximetasone has less risk of HPA-suppression than does topical clobetasol.
PMID: 28494626 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Clinical Trials | Clobetasol | Corticosteroid Therapy | Dermatology | Psoriasis | Skin | Statistics